Trending
November 25, 2024 AffyImmune Appoints Deyaa Adib, MD as Chief Medical OfficerNovember 25, 2024 Secretome Therapeutics Closes $20.4 Million FinancingNovember 25, 2024 Halcyon Closes $100M Series C FundingNovember 25, 2024 Fortress Acquires Infra Pipe SolutionsNovember 25, 2024 ICR Appoints J.D. Moriarty CEO of ICR Capital
Featured
November 25, 2024
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer
AffyImmune Therapeutics, a clinical-stage biotechnology company committed to developing its novel, first-in-class... Read more »
November 25, 2024
Secretome Therapeutics Closes $20.4 Million Financing
DALLAS--(BUSINESS WIRE)--Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal... Read more »
November 25, 2024
Halcyon Closes $100M Series C Funding
AUSTIN, Texas--(BUSINESS WIRE)--Halcyon, a leading platform designed from day one to defeat ransomware, today announced... Read more »
